Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Bullboard Posts
Post by mcnabbpaon Mar 19, 2013 8:37am
341 Views
Post# 21148984

FDA approval between now and max. Apr.30 imo

FDA approval between now and max. Apr.30 imo

 The good news for Ventripoint shareholders, other than the 510K acceptance, is that historically this type of device receives approval faster than any other, statistically speaking...appears to be an average of 60 days from date of submission, which would put us at end of April at the latest......check the last line of the 25 most common devices.

MC

How long does it takes for a FDA 510(k) submission to be reviewed?

Download the FDA 510(k) studyEmergo Group performed an analysis of publicly available FDA 510(k) data pulled from the FDA website on 15 January 2013. Data was pulled for the time period 1 January 2006 through 31 December 2011. Total number of records analyzed was 18,615. All data was sorted by the date FDA received a 510(k) submission, not the date it was cleared. Thus, 2010 data, for example, shows the statistics for all 510(k) submissions received by the FDA between 1 January 2010 and 31 December 2010. We only analyzed data for 510(k) submissions through the end of 2011 to allow a full 12 months for FDA 510(k) submissions to be cleared. Our analysis has shown that 95-97% of all 510(k) applications cleared by the FDA occur within one year of initial submission date. Data posted on January 31, 2013. Updated every year.

Download a PDF copy of this report


Total 510(k) submissions cleared by FDA per year

Number Cleared:
2006 – 3,325
2007 – 3,068
2008 – 3,134
2009 – 3,104
2010 – 2,929
2011 – 3,055 *

Comments:
After a sharp drop in submissions in 2010,the number FDA 510(k) submissions cleared by the FDA rebounded somewhat in 2011.

* Final numbers for 2011 may rise by 3-5% as submissions received by FDA in late 2011 are cleared by FDA in early 2013. Based on historical analysis, 95%-97% of cleared submissions happen within 12 months of submission to the FDA.

Average time for 510(k) submissions to clear

Average number of days to clearance:
2006 – 97 days
2007 – 110 days
2008 –118 days
2009 – 136 days
2010 – 146 days
2011 – 138 days

Comments:
After several years of ever lengthening review times, the trend reversed in 2011. The number of 510(k) submissions submitted in 2011 which cleared within 3 months increased to 42% from 40% and the average number of days decreased to 138 days.

Clearance time by device type

Comments:
On average, radiology products clear the 510(k) process more quickly than other categories of devices. Half of all products submitted for FDA 510(k) clearance fall into these four categories:

  • Orthopedic
  • Cardiovascular
  • General/Plastic Surgery
  • Radiology

25 most common devices subject to the FDA 510(k) process


FDA 510(k) submission by type: 2006-2011

Type of 510(k):
Traditional – 74%
Special – 22%
Abbreviated - 4%

These numbers have remained relatively constant from 2006-2011.

Based on analysis of 18,615 cleared 510(k) submissions from 1 January 2006 to 31 December  2011.

 

Bullboard Posts